OmniAb, Inc.
Market Cap
$208.29M
P/E Ratio
-3.21
EPS
$-0.57
Dividend Yield
0.00%
52-Week Range
$1.22 — $3.10
Volume
278.48K
Avg Volume
394.03K
Beta
0.85
P/E (TTM)
-3.21
Forward P/E
—
PEG Ratio
-2.12
P/S (TTM)
11.28
P/B (TTM)
0.89
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.24%
ROA (TTM)
-0.22%
ROIC
—
Gross Margin
0.73%
Operating Margin
-3.69%
Net Margin
—
Debt/Equity
0.08
Current Ratio
4.02
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-0.41%
EPS Growth (5Y)
-0.42%
Sales Growth (3Y)
+0.02%
Sales Growth (5Y)
+0.16%
EPS Est (This Year)
$-0.39
EPS Est (Next Year)
$-0.27
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.42
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
-84389
Outstanding Shares
107.62M
Float
75.39M
Free Float %
70.05%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2021-09-30
Employees
114
CEO
Matthew W. Foehr
Index Membership
—
Website
https://www.omniab.com
OmniAb, Inc. (OABI) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $208.29M, a P/E ratio of -3.21, OABI is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare OABI against other stocks using dozens of fundamental and technical filters.
OmniAb, Inc. (OABI) has a trailing twelve-month (TTM) P/E ratio of -3.21. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, OmniAb, Inc. (OABI) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
OmniAb, Inc. (OABI) has a market capitalization of $208.29 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.